Dupont De Nemours Inc Stock Price, News & Analysis

DuPont (NYSE: DD) announced a first quarter dividend of $0.30 per share, payable on March 15, 2021. Shareholders on record as of March 1, 2021 will receive this dividend. The company aims to reward its investors while continuing its role as a global innovation leader across various industries, including electronics and healthcare.

DuPont (NYSE: DD) reported fourth quarter 2020 financial results, achieving net sales of $5.3 billion, a 1% increase year-over-year. GAAP EPS from continuing operations rose to $0.37, attributed to favorable tax benefits despite higher depreciation. Operating EBITDA fell 7% to $1.3 billion. The Electronics & Imaging segment led growth with record sales of $1 billion, driven by semiconductors and smartphones. The company completed the divestiture of its Nutrition & Biosciences business, aiming to streamline operations. DuPont anticipates 2021 net sales between $15.4 and $15.6 billion, reflecting an 8% growth forecast.

DuPont announced the final results of its exchange offer related to the merger with International Flavors & Fragrances Inc. (IFF). A total of 368,655,051 shares were tendered, with a proration factor of 52.53%. Holders of 197,410,113 shares, approximately 27% of DuPont's outstanding shares, exchanged their stock for N&B common stock at an exchange ratio of 0.7180, resulting in receiving IFF shares post-merger. The transaction was supported by Goldman Sachs, J.P. Morgan, and Evercore as financial advisors.

An international private equity consortium, including BroadPeak Global, Asia Green Fund, and Dussur, has signed an agreement to acquire DuPont's Clean Technologies business for $510 million in cash. This transaction is set to close in Q2 2021, pending regulatory approvals. DuPont Clean Technologies is noted for its advancements in sulfuric acid production, hydroprocessing technology, and air pollution control systems. The Group aims to enhance the business's presence globally, particularly in addressing environmental issues and pushing for carbon neutrality.

DuPont (NYSE: DD) has completed its merger with IFF and Nutrition & Biosciences, receiving a $7.3 billion special cash payment. Approximately $5 billion will be allocated to reduce debt. The company is restructuring into three reporting segments: Electronics & Industrial, Mobility & Materials, and Water & Protection. This strategic focus aims to enhance growth potential and shareholder value. Additionally, DuPont plans to sell its Clean Technologies business for $510 million to further streamline operations. The changes are expected to position DuPont favorably as the global economy recovers.

DuPont has announced the preliminary results of its exchange offer related to its nutrition and biosciences business's merger with International Flavors & Fragrances. Approximately 369.2 million shares of DuPont common stock were tendered, leading to a preliminary proration factor of around 52.46%. This means that DuPont will exchange about 197.4 million shares for 141.7 million shares of its N&B common stock. The final proration factor will be determined after the guaranteed delivery period concludes on February 2, 2021.

DuPont has announced a final exchange ratio of 0.7180 shares of Nutrition & Biosciences, Inc. (N&B) for each share of DuPont common stock tendered in its exchange offer. This offer relates to DuPont's Reverse Morris Trust transaction with International Flavors & Fragrances Inc. (IFF). If fully subscribed, DuPont expects to exchange approximately 197.4 million shares. The exchange offer expires at 11:59 PM on January 29, 2021. N&B will merge with IFF, converting each N&B share into one share of IFF stock, affecting DuPont shareholders who tender their shares.

On December 31, 2020, DuPont commenced an exchange offer for stockholders to tender shares for Nutrition & Biosciences (N&B) stock. This action is part of a Reverse Morris Trust transaction with International Flavors & Fragrances (IFF). For Q4 2020, DuPont expects GAAP EPS between $0.35 and $0.37 on net sales of approximately $5.25 billion. Full year 2020 anticipates a GAAP loss per share of $(3.97) to $(3.95) on approximately $20.40 billion in sales. The final financial results will be announced on February 9, 2021.

DuPont, Corteva, and Chemours have reached a binding agreement to settle disputes related to Chemours' 2015 spin-off. This includes a cost-sharing arrangement for PFAS liabilities and an escrow account totaling $1 billion over eight years. DuPont and Corteva will split costs up to $2 billion, with Chemours contributing additional funds. The companies will also resolve PFOA litigation in Ohio for $83 million, with contributions from each firm. The agreement aims to provide security for shareholders against future environmental claims.